Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Investigative Medicine"
DOI: 10.1136/jim-2017-000609
Abstract: Data on cytokeratin-18 (K-18) and enhanced liver fibrosis (ELF) score in insulin-treated diabetes patients with non-alcoholic fatty liver disease (NAFLD) are limited. This study analyzed phase III data comparing basal insulin peglispro (BIL) and insulin… read more here.
Keywords: insulin; range; enhanced liver; type ... See more keywords